|
Q2 FY2027
As of Jul 31, 2026
|
Q1 FY2027
As of Apr 30, 2026
|
Q4 FY2026
As of Jan 31, 2026
|
Q3 FY2026
As of Oct 31, 2025
|
Q2 FY2026
As of Jul 31, 2025
|
Q1 FY2026
As of Apr 30, 2025
|
Q4 FY2025
As of Jan 31, 2025
|
Q3 FY2025
As of Oct 31, 2024
|
Q2 FY2025
As of Jul 31, 2024
|
Q1 FY2025
As of Apr 30, 2024
|
Q4 FY2024
As of Jan 31, 2024
|
Q3 FY2024
As of Oct 31, 2023
|
Q2 FY2024
As of Jul 31, 2023
|
Q1 FY2024
As of Apr 30, 2023
|
Q4 FY2023
As of Jan 31, 2023
|
Q3 FY2023
As of Oct 31, 2022
|
Q2 FY2023
As of Jul 31, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 31, 2022
|
Q3 FY2022
As of Oct 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net - unbilled | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Total | ||||||||||||||||||||
| Total Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Interest payable | ||||||||||||||||||||
| Accrued payroll expenses | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Accrued tax expenses | ||||||||||||||||||||
| Current portion long term debt | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Accrued interest due to related party | ||||||||||||||||||||
| Accrued payroll and tax expenses | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Current portion SBA loan interest | ||||||||||||||||||||
| Current portion SBA loan | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-term Liabilities | ||||||||||||||||||||
| Accrued interest long term portion | ||||||||||||||||||||
| SBA loan | ||||||||||||||||||||
| Long term portion notes payable | ||||||||||||||||||||
| Total Long-term Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Commitments and Contingencies - Note 7 | ||||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||||
| Authorized 200,000,000 shares of common stock, $0.001 par value, Issued and outstanding 103,330,799 shares of common stock as of July 31, 2026 and January 31, 2026 | ||||||||||||||||||||
| Additional Paid In Capital | ||||||||||||||||||||
| Accumulated Deficit | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders' Deficit | ||||||||||||||||||||
Loading...
